Literature DB >> 28941533

Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children.

Sabrina M Heidemann1, Alison Nair2, Yonca Bulut3, Anil Sapru4.   

Abstract

Acute respiratory distress syndrome (ARDS) is a syndrome of noncardiogenic pulmonary edema and hypoxia that accompanies up to 30% of deaths in pediatric intensive care units. Pediatric ARDS (PARDS) is diagnosed by the presence of hypoxia, defined by oxygenation index or Pao2/Fio2 ratio cutoffs, and new chest infiltrate occurring within 7 days of a known insult. Hallmarks of ARDS include hypoxemia and decreased lung compliance, increased work of breathing, and impaired gas exchange. Mortality is often accompanied by multiple organ failure. Although many modalities to treat PARDS have been investigated, supportive therapies and lung protective ventilator support remain the mainstay.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Acute respiratory distress syndrome; PARDS; Pathophysiology; Pediatrics

Mesh:

Year:  2017        PMID: 28941533     DOI: 10.1016/j.pcl.2017.06.004

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  8 in total

Review 1.  Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS).

Authors:  Lynne Rosenberg; Chani Traube
Journal:  Ann Transl Med       Date:  2019-10

2.  Exome sequencing contributes to identify comorbidities in a rare case of infant ARDS induced by the CD40LG mutation.

Authors:  Xue Gong; Yunru He; Guoyan Lu; Yulin Zhang; Yu Qiu; Lina Qiao; Yifei Li
Journal:  BMC Med Genomics       Date:  2022-07-08       Impact factor: 3.622

Review 3.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

Review 4.  Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.

Authors:  Carsten W Lederer; Lola Koniali; Tina Buerki-Thurnherr; Panayiota L Papasavva; Stefania La Grutta; Amelia Licari; Frantisek Staud; Donato Bonifazi; Marina Kleanthous
Journal:  Pharmaceutics       Date:  2022-04-05       Impact factor: 6.525

5.  The Clinical Characteristics of ARDS in Children With Hematological Neoplasms.

Authors:  Qiao Zhang; Wen-Ting Hu; Fan Yin; Han Qian; Ying Wang; Bi-Ru Li; Juan Qian; Yan-Jing Tang; Bo-Tao Ning
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418

6.  Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome.

Authors:  Mark R Hanudel; Matthew S Zinter; Lucia Chen; Kinisha Gala; Michelle Lim; Mona Guglielmo; Tanaya Deshmukh; Sitaram Vangala; Michael Matthay; Anil Sapru
Journal:  PLoS One       Date:  2019-09-05       Impact factor: 3.240

7.  Acute Respiratory Distress Syndrome Management in Pediatric Intensive Care Units in Turkey: A Prospective Survey.

Authors:  Resul Yılmaz; Enes Türkyılmaz; Özlem Ülkü Karataş; Hatice Kübra Samancı
Journal:  Turk Arch Pediatr       Date:  2022-03

8.  Knockdown of receptor interacting protein 140 (RIP140) alleviated lipopolysaccharide-induced inflammation, apoptosis and permeability in pulmonary microvascular endothelial cells by regulating C-terminal binding protein 2 (CTBP2).

Authors:  Qizheng Wang; Qiong Wu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.